Available webcasts will be accessible on Skye’s website.

Castle will also be available for one-on-one investor meetings during the Wells Fargo 20 th Annual Healthcare Conference on Sept. 4, 2025, and the 9 th Annual Lake Street Best Ideas Growth (BIG9) ...

ROCKVILLE, Md., Aug. 21, 2025 (GLOBE NEWSWIRE) -- I-Mab (NASDAQ: IMAB) (the “Company”), a U.S.-based, global biotech company, focused on the development of precision immuno-oncology agents for the ...

COPENHAGEN, Denmark – August 21, 2025. Novonesis delivered 9% organic sales growth in H1 and full-year outlook range narrowed to 6-8%. En cliquant sur ce lien, vous acceptez l'utilisation de cookies ...

A presentation of the results of the Denali trial is available on our website, www.nicox.com.

Nicox SA (Euronext Growth Paris : FR0013018124, ALCOX, éligible PEA-PME), une société internationale spécialisée en ophtalmologie, annonce aujourd’hui que l’administration quotidienne en une seule dos ...

Following a successful execution in the first half of the year, and GN’s company-wide agility, the financial guidance for 2025 is confirmed. The organic revenue growth guidance of -3% to +3% ...

2025 outlook: Organic sales growth range narrowed to 6-8% (previously 5-8%), and 7-9% excluding the exit from certain countries (previously 6-9%). Adjusted EBITDA margin is maintained at 37-38%, ...

Cantor is acting as sole book-running manager for the offering.

An investor webcast and conference call will be held at 9.30am AEST on Thursday 21 August 2025 (7.30pm EDT Wednesday 20 August 2025). Participants can register for the webcast by clicking here: or ...

T1DM is an autoimmune disorder characterized by the destruction of beta cells, resulting in an absolute deficiency of insulin ...

MyndMed™’s formula, developed by BioAdaptives’ research team, incorporates a precise blend of botanical extracts, amino acids, and neuro-support nutrients designed to support neurotransmitter balance, ...